CABALETTA BIO INC. -
4.4800
18-September-24 14:59:56
15 minutes delayed
Stocks
+0.2900
+6.92%
Today's range
4.1800 - 5.0400
ISIN
N/A
Source
NASDAQ
-
01 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
28 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Announces Appointment of Michael Gerard as General Counsel
07 Sep 2021 07:00:03 By Nasdaq GlobeNewswire
-
18 Aug 2021 06:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2021 Financial Results and Provides Business Update
05 Aug 2021 06:30:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. to Board of Directors
28 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Jefferies Healthcare Conference
27 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates
03 May 2021 06:05:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes™ Trial
03 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference
07 Apr 2021 07:00:02 By Nasdaq GlobeNewswire
-
16 Mar 2021 06:30:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in March
23 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 Jan 2021 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming January Investor Conferences
04 Jan 2021 07:00:00 By Nasdaq GlobeNewswire